Can Machine Learning Save Innovation in Pharmaceuticals?

Posted on

Have the economics of investing in new drug discovery and development become so unattractive that investment in new drugs will come to a halt? GlaxoSmithKline and other bio-pharmaceutical companies are turning to machine learning as a potential solution to make the drug discovery process more efficient, with the hopes of greatly reducing both the time and cost associated with R&D.

How Big is Amazon’s Opportunity in Healthcare?

Posted on

In October 2017, reports surfaced stating that Amazon’s entry into healthcare was imminent. Overnight, stock prices for top pharmacies, PBMs, and wholesalers plummeted, losing a sum total of ~$40B in market capitalization [1].

But how well-equipped is Amazon to disrupt the entire healthcare supply chain?

Having worked as a healthcare consultant, and as a member of a family entrenched in the business of healthcare, I can say: this is one of the most critical unknowns facing the industry.